Skip to content

Relation between globus pharyngeus and obstructive sleep apnea (OSA) and GERD in patients examined simultaneously by PSG and pH monitor: a cross sectional study

Relation between globus pharyngeus and obstructive sleep apnea (OSA) and GERD in patients examined simultaneously by PSG and pH monitor: a cross sectional study - Relation between globus pharyngeus and obstructive sleep apnea (OSA) and GERD in patients examined simultaneously by PSG and pH monitor: a cross sectional study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000028244
Enrollment
30
Registered
2017-07-18
Start date
2013-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Globus pharyngeus obstructive sleep apnea (OSA) gastroesophageal reflux disease (GERD)

Interventions

None listed

Sponsors

Department of otolaryngology,Nagoya city University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who have non-painful sensation of a lump or foreign body in the throat for more than 3 months.

Exclusion criteria

Exclusion criteria: 1)Patients who can not quit peptic ulcer treatment (PPI, H2 blocker,etc) 2)Patients with any mental disorder or those who had been instructed to continue all medications that could influence sleep, such as benzodiazepines, were excluded as well. 3)other reasons inadequate for study participation

Design outcomes

Primary

MeasureTime frame
Simultaneously PSG and 24-hour pH monitoring are performed on patients with globus pharyngeus, and the prevalence rate of OSA andGERD is obtained.

Secondary

MeasureTime frame
Patients with OSA are treated with CPAP. Compare the VAS of symptoms of globus pharyngeus before treatment and 3 months after treatment and evaluate improvement.

Countries

Japan

Contacts

Public Contactayako fukui

Nagoya city University Department of otolaryngology

bunko-0406@hotmail.co.jp052-851-5511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026